Citations (30)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Pawan Kumar Doharey, Vishal Singh, Mallikarjuna Rao Gedda, Amaresh Kumar Sahoo, Pritish Kumar Varadwaj & Bechan Sharma. (2022) In silico study indicates antimalarials as direct inhibitors of SARS-CoV-2-RNA dependent RNA polymerase. Journal of Biomolecular Structure and Dynamics 40:12, pages 5588-5605.
Read now
Read now
Paolo Sfriso, Sara Bindoli, Andrea Doria, Eugen Feist & Paola Galozzi. (2020) Canakinumab for the treatment of adult-onset Still’s disease. Expert Review of Clinical Immunology 16:2, pages 129-138.
Read now
Read now
Kiyoshi Migita, Tomoyuki Asano, Shuzo Sato, Tomohiro Koga, Yuya Fujita & Atsushi Kawakami. (2018) Familial Mediterranean fever: overview of pathogenesis, clinical features and management . Immunological Medicine 41:2, pages 55-61.
Read now
Read now
Articles from other publishers (27)
Manisha Singh. 2023. Multifaceted Role of IL-1 in Cancer and Inflammation. Multifaceted Role of IL-1 in Cancer and Inflammation
87
98
.
Rajdeep Pooni & Imelda Balboni. 2023. Encyclopedia of Child and Adolescent Health. Encyclopedia of Child and Adolescent Health
627
650
.
Dimitri Poddighe, Micol Romano, Facundo Garcia‐Bournissen & Erkan Demirkaya. (2021) Conventional and novel therapeutic options in children with familial Mediterranean fever: A rare autoinflammatory disease. British Journal of Clinical Pharmacology 88:6, pages 2484-2499.
Crossref
Crossref
Xi Yin, Fangyuan Tian, Bin Wu & Ting Xu. (2022) Interventions for reducing inflammation in familial Mediterranean fever. Cochrane Database of Systematic Reviews 2022:3.
Crossref
Crossref
João P. Luís, Carlos J. V. Simões & Rui M. M. Brito. (2022) The Therapeutic Prospects of Targeting IL-1R1 for the Modulation of Neuroinflammation in Central Nervous System Disorders. International Journal of Molecular Sciences 23:3, pages 1731.
Crossref
Crossref
Yusuf Karabulut, Halise Hande Gezer & Mehmet Tuncay Duruöz. (2021) Canakinumab is effective in patients with familial Mediterranean fever resistant and intolerant to the colchicine and/or anakinra treatment. Rheumatology International 42:1, pages 81-86.
Crossref
Crossref
Tom Macleod, Anna Berekmeri, Charlie Bridgewood, Martin Stacey, Dennis McGonagle & Miriam Wittmann. (2021) The Immunological Impact of IL-1 Family Cytokines on the Epidermal Barrier. Frontiers in Immunology 12.
Crossref
Crossref
Sussi B. Mortensen, Ann‐Brit E. Hansen, Trine H. Mogensen, Marianne A. Jakobsen, Hans C. Beck, Eva B. Harvald, Kate L. Lambertsen, Isik S. Johansen & Ditte C. Andersen. (2021) Pyrin Inflammasome Activation Abrogates Interleukin‐1 Receptor Antagonist, Suggesting a New Mechanism Underlying Familial Mediterranean Fever Pathogenesis. Arthritis & Rheumatology 73:11, pages 2116-2126.
Crossref
Crossref
Abdolreza Esmaeilzadeh, Samaneh Rostami, Pegah M. Yeganeh, Safa Tahmasebi & Majid Ahmadi. (2021) Recent advances in antibody‐based immunotherapy strategies for COVID‐19. Journal of Cellular Biochemistry 122:10, pages 1389-1412.
Crossref
Crossref
Fengjie Liu, Lihong Li, Meng Lan, Tengteng Zou, Zhaodi Kong, Tiange Cai, Xiao Yu Wu & Yu Cai. (2021) Key Factor Regulating Inflammatory Microenvironment, Metastasis, and Resistance in Breast Cancer: Interleukin-1 Signaling. Mediators of Inflammation 2021, pages 1-18.
Crossref
Crossref
Mengda Xu, Kailun Zhang & Jiangping Song. (2021) Targeted Therapy in Cardiovascular Disease: A Precision Therapy Era. Frontiers in Pharmacology 12.
Crossref
Crossref
T. Sahr, U. Kiltz, C. Weseloh, T. Kallinich & J. Braun. (2020) Ergebnisse der systematischen Literatursuche als Grundlage für die „evidenzbasierten Therapieempfehlungen für FMF-Patienten mit unzureichendem Ansprechen bzw. Unverträglichkeit auf Kolchizin“ der Gesellschaft für Kinder- und Jugendrheumatologie und der Deutschen Gesellschaft für RheumatologieResults of the systematic literature search as basis for the “Evidence-based treatment recommendations for familial Mediterranean fever patients with insufficient response or intolerability to colchicine” of the Society for Pediatric and Adolescent Rheumatology and the German Society for Rheumatology. Zeitschrift für Rheumatologie 79:9, pages 943-951.
Crossref
Crossref
Giuseppe Magro. (2020) COVID-19: Review on latest available drugs and therapies against SARS-CoV-2. Coagulation and inflammation cross-talking. Virus Research 286, pages 198070.
Crossref
Crossref
Huri Ozdogan, Serdal Ugurlu, Ugur Uygunoglu, Melih Tutuncu, Ahmet Gul, Gulsen Akman & Aksel Siva. (2020) The efficacy of anti- IL-1 treatment in three patients with coexisting familial mediterranean fever and multiple sclerosis. Multiple Sclerosis and Related Disorders, pages 102332.
Crossref
Crossref
Hakan Babaoglu, Ozkan Varan, Hamit Kucuk, Nuh Atas, Hasan Satis, Reyhan Salman, Mehmet Akif Ozturk, Berna Goker, Abdurrahman Tufan & Seminur Haznedaroglu. (2020) Effectiveness of Canakinumab in Colchicine- and Anakinra-Resistant or -Intolerant Adult Familial Mediterranean Fever Patients. JCR: Journal of Clinical Rheumatology 26:1, pages 7-13.
Crossref
Crossref
Hakan Emmungil, Ufuk İlgen, Sezin Turan, Samet Yaman & Orhan Küçükşahin. (2019) Different pharmaceutical preparations of colchicine for Familial Mediterranean Fever: are they the same?. Rheumatology International 40:1, pages 129-135.
Crossref
Crossref
Charles Anthony Dinarello. (2019) The IL-1 family of cytokines and receptors in rheumatic diseases. Nature Reviews Rheumatology 15:10, pages 612-632.
Crossref
Crossref
Arnon Blum & Mohammad Adawi. (2019) RETRACTED: Rheumatoid arthritis (RA) and cardiovascular disease. Autoimmunity Reviews 18:7, pages 679-690.
Crossref
Crossref
Huri Ozdogan & Serdal Ugurlu. (2019) Familial Mediterranean Fever. La Presse Médicale 48:1, pages e61-e76.
Crossref
Crossref
T. Kallinich, N. Blank, T. Braun, E. Feist, U. Kiltz, U. Neudorf, P. T. Oommen, C. Weseloh, H. Wittkowski & J. Braun. (2019) Evidenzbasierte Therapieempfehlungen für das familiäre MittelmeerfieberEvidence-based treatment recommendations for familial Mediterranean fever. Zeitschrift für Rheumatologie 78:1, pages 91-101.
Crossref
Crossref
Shai Padeh, Yelda Bilginer & Seza Ozen. 2019. Textbook of Autoinflammation. Textbook of Autoinflammation
293
313
.
Bin Wu, Ting Xu, Youping Li & Xi Yin. (2018) Interventions for reducing inflammation in familial Mediterranean fever. Cochrane Database of Systematic Reviews 2018:10.
Crossref
Crossref
Ricardo O. Escárcega, Michael J. Lipinski, Mario García-Carrasco, Claudia Mendoza-Pinto, Jose Luis Galvez-Romero & Ricard Cervera. (2018) Inflammation and atherosclerosis: Cardiovascular evaluation in patients with autoimmune diseases. Autoimmunity Reviews 17:7, pages 703-708.
Crossref
Crossref
Apurva Kanneganti, R.K. Subbarao Malireddi, Pedro H.V. Saavedra, Lieselotte Vande Walle, Hanne Van Gorp, Hiroto Kambara, Heather Tillman, Peter Vogel, Hongbo R. Luo, Ramnik J. Xavier, Hongbo Chi & Mohamed Lamkanfi. (2018) GSDMD is critical for autoinflammatory pathology in a mouse model of Familial Mediterranean Fever. Journal of Experimental Medicine 215:6, pages 1519-1529.
Crossref
Crossref
Fatma Yazılıtaş, Özlem Aydoğ, Sare Gülfem Özlü, Evrim Kargın Çakıcı, Tülin Güngör, Fehime Kara Eroğlu, Gökçe Gür & Mehmet Bülbül. (2018) Canakinumab treatment in children with familial Mediterranean fever: report from a single center. Rheumatology International 38:5, pages 879-885.
Crossref
Crossref
Tomohiro Koga, Kiyoshi Migita, Tomohito Sato, Shuntaro Sato, Masataka Umeda, Fumiaki Nonaka, Shoichi Fukui, Shin-ya Kawashiri, Naoki Iwamoto, Kunihiro Ichinose, Mami Tamai, Hideki Nakamura, Tomoki Origuchi, Yukitaka Ueki, Junya Masumoto, Kazunaga Agematsu, Akihiro Yachie, Koh-ichiro Yoshiura, Katsumi Eguchi & Atsushi Kawakami. (2018) MicroRNA-204-3p inhibits lipopolysaccharide-induced cytokines in familial Mediterranean fever via the phosphoinositide 3-kinase γ pathway. Rheumatology 57:4, pages 718-726.
Crossref
Crossref
Donato Rigante. (2018) New mosaic tiles in childhood hereditary autoinflammatory disorders. Immunology Letters 193, pages 67-76.
Crossref
Crossref